Recognition and management of sleep-disordered breathing in chronic heart failure

被引：9
作者：
Kahwash R. [1 ]
Kikta D. [1 ]
Khayat R. [2 ]
机构：
[1] Division of Cardiovascular Medicine, Section of Heart Failure and Transplant, Davis Heart/Lung Research Institute, Columbus, OH 43210
[2] Sleep Heart Program, Division of Cardiovascular Medicine, Davis Heart/Lung Research Institute, Columbus, OH 43210
来源：
Current Heart Failure Reports | 2011年 / 8卷 / 1期
关键词：
Central sleep apnea; Chronic systolic heart failure; Obstructive sleep apnea; Positive airway pressure; Respiration;
D O I：
10.1007/s11897-010-0037-1
中图分类号：
学科分类号：
摘要：
It is increasingly recognized that sleep-disordered breathing (SDB) is a common modifiable risk factor for cardiovascular disease with significant impact on morbidity and potentially mortality. SDB is highly prevalent in patients with systolic or diastolic heart failure. A high index of suspicion is necessary to diagnose SDB in patients with heart failure because the vast majority of affected patients do not report daytime symptoms. Recent clinical trials have demonstrated improvement in heart function, exercise tolerance, and quality of life after treatment of SDB in patients with heart failure. Accumulating evidence suggests that treatment of SDB should complement the established pharmacologic therapy for chronic heart failure. However, mortality benefit has yet to be demonstrated. © 2010 Springer Science+Business Media, LLC.
引用
收藏
页码：72 / 79
页数：7
相关论文
共 43 条
  • [1] Mansfield D.R., Gollogly N.C., Kaye D.M., Richardson M., Bergin P., Naughton M.T., Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure, Am J Respir Crit Care Med, 169, 3, pp. 361-366, (2004)
  • [2] Javaheri S., Caref E.B., Chen E., Tong K.B., Abraham W.T., Sleep Apnea Testing and Outcomes in a Large Cohort of Medicare Beneficiaries with Newly Diagnosed Heart Failure, Am J Respir Crit Care Med, (2010)
  • [3] Teschler H., Dohring J., Wang Y.M., Berthon-Jones M., Adaptive pressure support servo-ventilation: A novel treatment for Cheyne-Stokes respiration in heart failure, Am J Respir Crit Care Med, 164, 4, pp. 614-619, (2001)
  • [4] Young T., Palta M., Dempsey J., Skatrud J., Weber S., Badr S., The occurrence of sleep-disordered breathing among middle-aged adults, New England Journal of Medicine, 328, 17, pp. 1230-1235, (1993)
  • [5] Javaheri S., Parker T.J., Liming J.D., Corbett W.S., Nishiyama H., Wexler L., Roselle G.A., Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalences, consequences, and presentations, Circulation, 97, 21, pp. 2154-2159, (1998)
  • [6] Khayat R., Jarjoura D., Patt B., Yamokoski T., Abraham W.T., In-hospital Testing for Sleep-disordered Breathing in Hospitalized Patients with Decompensated Heart Failure: Report of Prevalence and Patient Characteristics, Journal of Cardiac Failure, (2009)
  • [7] Young T., Peppard P., Palta M., Hla K.M., Finn L., Morgan B., Skatrud J., Population-based study of sleep-disordered breathing as a risk factor for hypertension, Archives of Internal Medicine, 157, 15, pp. 1746-1752, (1997)
  • [8] Peppard P.E., Young T., Palta M., Skatrud J., Prospective study of the association between sleep-disordered breathing and hypertension, New England Journal of Medicine, 342, 19, pp. 1378-1384, (2000)
  • [9] Peker Y., Hedner J., Kraiczi H., Loth S., Respiratory disturbance index: An independent predictor of mortality in coronary artery disease, Am J Respir Crit Care Med, 162, 1, pp. 81-86, (2000)
  • [10] Marin J.M., Carrizo S.J., Vicente E., Agusti A.G., Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: An observational study, Lancet, 365, 9464, pp. 1046-1053, (2005)
12345